{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T12:53:12Z","timestamp":1786971192607,"version":"build-2736575974"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2007,9,24]],"date-time":"2007-09-24T00:00:00Z","timestamp":1190592000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2007,9,24]],"date-time":"2007-09-24T00:00:00Z","timestamp":1190592000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Bone Marrow Transplant"],"published-print":{"date-parts":[[2007,12]]},"DOI":"10.1038\/sj.bmt.1705857","type":"journal-article","created":{"date-parts":[[2007,9,24]],"date-time":"2007-09-24T10:43:11Z","timestamp":1190630591000},"page":"1033-1037","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":54,"title":["Lack of CD56 expression on myeloma cells is not a marker for poor prognosis in patients treated by high-dose chemotherapy and is associated with translocation t(11;14)"],"prefix":"10.1038","volume":"40","author":[{"given":"M","family":"Hundemer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Hose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-S","family":"Raab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F W","family":"Cremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Benner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hei\u00df","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Moos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A D","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Goldschmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,9,24]]},"reference":[{"key":"BF1705857_CR1","doi-asserted-by":"publisher","first-page":"3469","DOI":"10.1182\/blood-2003-01-0073","volume":"102","author":"J Blade","year":"2003","unstructured":"Blade J, Vesole DH, Gertz M . High-dose therapy in multiple myeloma. Blood 2003; 102: 3469\u20133470.","journal-title":"Blood"},{"key":"BF1705857_CR2","doi-asserted-by":"publisher","first-page":"1860","DOI":"10.1056\/NEJMra041875","volume":"351","author":"RA Kyle","year":"2004","unstructured":"Kyle RA, Rajkumar SV . Multiple myeloma. N Engl J Med 2004; 351: 1860\u20131873.","journal-title":"N Engl J Med"},{"key":"BF1705857_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1126\/science.3281256","volume":"240","author":"U Rutishauser","year":"1988","unstructured":"Rutishauser U, Acheson A, Hall AK, Mann DM, Sunshine J . The neural cell adhesion molecule (NCAM) as a regulator of cell\u2013cell interactions. Science 1988; 240: 53\u201357.","journal-title":"Science"},{"key":"BF1705857_CR4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/15419060214520","volume":"9","author":"RA Blaheta","year":"2002","unstructured":"Blaheta RA, Hundemer M, Mayer G, Vogel JU, Kornhuber B, Cinatl J et al. Expression level of neural cell adhesion molecule (NCAM) inversely correlates with the ability of neuroblastoma cells to adhere to endothelium in vitro. Cell Commun Adhes 2002; 9: 131\u2013147.","journal-title":"Cell Commun Adhes"},{"key":"BF1705857_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1593\/neo.03418","volume":"6","author":"RA Blaheta","year":"2004","unstructured":"Blaheta RA, Beecken WD, Engl T, Jonas D, Oppermann E, Hundemer M et al. Human cytomegalovirus infection of tumor cells downregulates NCAM (CD56): a novel mechanism for virus-induced tumor invasiveness. Neoplasia 2004; 6: 323\u2013331.","journal-title":"Neoplasia"},{"key":"BF1705857_CR6","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1046\/j.1365-2141.2002.03513.x","volume":"117","author":"N Sahara","year":"2002","unstructured":"Sahara N, Takeshita A, Shigeno K, Fujisawa S, Takeshita K, Naito K et al. Clinicopathological and prognostic characteristics of CD56-negative multiple myeloma. Br J Haematol 2002; 117: 882\u2013885.","journal-title":"Br J Haematol"},{"key":"BF1705857_CR7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1182\/blood.V76.2.377.377","volume":"76","author":"CB Van","year":"1990","unstructured":"Van CB, Durie BG, Spier C, De WM, Van RI, Vela E et al. Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56 (NKH-1; Leu-19). Blood 1990; 76: 377\u2013382.","journal-title":"Blood"},{"key":"BF1705857_CR8","doi-asserted-by":"crossref","first-page":"2658","DOI":"10.1182\/blood.V81.10.2658.2658","volume":"81","author":"H Harada","year":"1993","unstructured":"Harada H, Kawano MM, Huang N, Harada Y, Iwato K, Tanabe O et al. Phenotypic difference of normal plasma cells from mature myeloma cells. Blood 1993; 81: 2658\u20132663.","journal-title":"Blood"},{"key":"BF1705857_CR9","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1309\/74R4TB90BUWH27JX","volume":"121","author":"P Lin","year":"2004","unstructured":"Lin P, Owens R, Tricot G, Wilson CS . Flow cytometric immunophenotypic analysis of 306 cases of multiple myeloma. Am J Clin Pathol 2004; 121: 482\u2013488.","journal-title":"Am J Clin Pathol"},{"key":"BF1705857_CR10","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1046\/j.1365-2141.1999.01134.x","volume":"104","author":"A Rawstron","year":"1999","unstructured":"Rawstron A, Barrans S, Blythe D, Davies F, English A, Pratt G et al. Distribution of myeloma plasma cells in peripheral blood and bone marrow correlates with CD56 expression. Br J Haematol 1999; 104: 138\u2013143.","journal-title":"Br J Haematol"},{"key":"BF1705857_CR11","doi-asserted-by":"publisher","first-page":"375","DOI":"10.1111\/j.1365-2559.2004.01834.x","volume":"44","author":"P Martin","year":"2004","unstructured":"Martin P, Santon A, Bellas C . Neural cell adhesion molecule expression in plasma cells in bone marrow biopsies and aspirates allows discrimination between multiple myeloma, monoclonal gammopathy of uncertain significance and polyclonal plasmacytosis. Histopathology 2004; 44: 375\u2013380.","journal-title":"Histopathology"},{"key":"BF1705857_CR12","doi-asserted-by":"publisher","first-page":"1293","DOI":"10.1016\/S0002-9440(10)62556-4","volume":"160","author":"SA Ely","year":"2002","unstructured":"Ely SA, Knowles DM . Expression of CD56\/neural cell adhesion molecule correlates with the presence of lytic bone lesions in multiple myeloma and distinguishes myeloma from monoclonal gammopathy of undetermined significance and lymphomas with plasmacytoid differentiation. Am J Pathol 2002; 160: 1293\u20131299.","journal-title":"Am J Pathol"},{"key":"BF1705857_CR13","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1002\/path.1680","volume":"205","author":"M Kremer","year":"2005","unstructured":"Kremer M, Ott G, Nathrath M, Specht K, Stecker K, Alexiou C et al. Primary extramedullary plasmacytoma and multiple myeloma: phenotypic differences revealed by immunohistochemical analysis. J Pathol 2005; 205: 92\u2013101.","journal-title":"J Pathol"},{"key":"BF1705857_CR14","doi-asserted-by":"publisher","first-page":"1977","DOI":"10.1038\/sj.leu.2401211","volume":"12","author":"C Pellat-Deceunynck","year":"1998","unstructured":"Pellat-Deceunynck C, Barille S, Jego G, Puthier D, Robillard N, Pineau D et al. The absence of CD56 (NCAM) on malignant plasma cells is a hallmark of plasma cell leukemia and of a special subset of multiple myeloma. Leukemia 1998; 12: 1977\u20131982.","journal-title":"Leukemia"},{"key":"BF1705857_CR15","first-page":"3647","volume":"55","author":"C Pellat-Deceunynck","year":"1995","unstructured":"Pellat-Deceunynck C, Barille S, Puthier D, Rapp MJ, Harousseau JL, Bataille R et al. Adhesion molecules on human myeloma cells: significant changes in expression related to malignancy, tumor spreading, and immortalization. Cancer Res 1995; 55: 3647\u20133653.","journal-title":"Cancer Res"},{"key":"BF1705857_CR16","doi-asserted-by":"crossref","first-page":"3151","DOI":"10.1182\/blood.V86.8.3151.3151","volume":"86","author":"S Barille","year":"1995","unstructured":"Barille S, Collette M, Bataille R, Amiot M . Myeloma cells upregulate interleukin-6 secretion in osteoblastic cells through cell-to-cell contact but downregulate osteocalcin. Blood 1995; 86: 3151\u20133159.","journal-title":"Blood"},{"key":"BF1705857_CR17","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1080\/10428190500272549","volume":"47","author":"H Chang","year":"2006","unstructured":"Chang H, Samiee S, Yi QL . Prognostic relevance of CD56 expression in multiple myeloma: a study including 107 cases treated with high-dose melphalan-based chemotherapy and autologous stem cell transplant. Leuk Lymphoma 2006; 47: 43\u201347.","journal-title":"Leuk Lymphoma"},{"key":"BF1705857_CR18","doi-asserted-by":"crossref","first-page":"4250","DOI":"10.1182\/blood.V86.11.4250.bloodjournal86114250","volume":"86","author":"G Tricot","year":"1995","unstructured":"Tricot G, Barlogie B, Jagannath S, Bracy D, Mattox S, Vesole DH et al. Poor prognosis in multiple myeloma is associated only with partial or complete deletions of chromosome 13 or abnormalities involving 11q and not with other karyotype abnormalities. Blood 1995; 86: 4250\u20134256.","journal-title":"Blood"},{"key":"BF1705857_CR19","doi-asserted-by":"publisher","first-page":"3735","DOI":"10.1182\/blood.V99.10.3735","volume":"99","author":"R Fonseca","year":"2002","unstructured":"Fonseca R, Blood EA, Oken MM, Kyle RA, Dewald GW, Bailey RJ et al. Myeloma and the t(11;14)(q13;q32); evidence for a biologically defined unique subset of patients. Blood 2002; 99: 3735\u20133741.","journal-title":"Blood"},{"key":"BF1705857_CR20","doi-asserted-by":"publisher","first-page":"1505","DOI":"10.1016\/S0002-9440(10)65022-5","volume":"156","author":"G Pruneri","year":"2000","unstructured":"Pruneri G, Fabris S, Baldini L, Carboni N, Zagano S, Colombi MA et al. Immunohistochemical analysis of cyclin D1 shows deregulated expression in multiple myeloma with the t(11;14). Am J Pathol 2000; 156: 1505\u20131513.","journal-title":"Am J Pathol"},{"key":"BF1705857_CR21","doi-asserted-by":"publisher","first-page":"2032","DOI":"10.1038\/sj.leu.2403091","volume":"17","author":"R Garand","year":"2003","unstructured":"Garand R, Avet-Loiseau H, Accard F, Moreau P, Harousseau JL, Bataille R . t(11;14) and t(4;14) translocations correlated with mature lymphoplasmacytoid and immature morphology, respectively, in multiple myeloma. Leukemia 2003; 17: 2032\u20132035.","journal-title":"Leukemia"},{"key":"BF1705857_CR22","doi-asserted-by":"publisher","first-page":"1588","DOI":"10.1182\/blood-2002-12-3789","volume":"102","author":"S Soverini","year":"2003","unstructured":"Soverini S, Cavo M, Cellini C, Terragna C, Zamagni E, Ruggeri D et al. Cyclin D1 overexpression is a favorable prognostic variable for newly diagnosed multiple myeloma patients treated with high-dose chemotherapy and single or double autologous transplantation. Blood 2003; 102: 1588\u20131594.","journal-title":"Blood"},{"key":"BF1705857_CR23","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/gcc.2870040109","volume":"4","author":"T Ried","year":"1992","unstructured":"Ried T, Lengauer C, Cremer T, Wiegant J, Raap AK, van der PM et al. Specific metaphase and interphase detection of the breakpoint region in 8q24 of Burkitt lymphoma cells by triple-color fluorescence in situ hybridization. Genes Chromosomes Cancer 1992; 4: 69\u201374.","journal-title":"Genes Chromosomes Cancer"},{"key":"BF1705857_CR24","first-page":"187","volume":"41","author":"R Gill","year":"1982","unstructured":"Gill R . Understanding Cox's regression model. Experientia Suppl 1982; 41: 187\u2013199.","journal-title":"Experientia Suppl"},{"key":"BF1705857_CR25","doi-asserted-by":"publisher","first-page":"3661","DOI":"10.1158\/1078-0432.CCR-04-1489","volume":"11","author":"G Mateo","year":"2005","unstructured":"Mateo G, Castellanos M, Rasillo A, Gutierrez NC, Montalban MA, Martin ML et al. Genetic abnormalities and patterns of antigenic expression in multiple myeloma. Clin Cancer Res 2005; 11: 3661\u20133667.","journal-title":"Clin Cancer Res"},{"key":"BF1705857_CR26","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1182\/blood.V95.6.1925","volume":"95","author":"N Zojer","year":"2000","unstructured":"Zojer N, Konigsberg R, Ackermann J, Fritz E, Dallinger S, Kromer E et al. Deletion of 13q14 remains an independent adverse prognostic variable in multiple myeloma despite its frequent detection by interphase fluorescence in situ hybridization. Blood 2000; 95: 1925\u20131930.","journal-title":"Blood"},{"key":"BF1705857_CR27","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1182\/blood-2002-03-0749","volume":"100","author":"P Moreau","year":"2002","unstructured":"Moreau P, Facon T, Leleu X, Morineau N, Huyghe P, Harousseau JL et al. Recurrent 14q32 translocations determine the prognosis of multiple myeloma, especially in patients receiving intensive chemotherapy. Blood 2002; 100: 1579\u20131583.","journal-title":"Blood"}],"container-title":["Bone Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/1705857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705857","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/1705857.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,24]],"date-time":"2022-03-24T00:36:41Z","timestamp":1648082201000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/1705857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,9,24]]},"references-count":27,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2007,12]]}},"alternative-id":["BF1705857"],"URL":"https:\/\/doi.org\/10.1038\/sj.bmt.1705857","relation":{},"ISSN":["0268-3369","1476-5365"],"issn-type":[{"value":"0268-3369","type":"print"},{"value":"1476-5365","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,9,24]]},"assertion":[{"value":"14 May 2007","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2007","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 August 2007","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 September 2007","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}